Cancer is becoming a major cause of death worldwide. With the increase in life expectancy, the number of cancer cases has reached to peak levels. In this scenario, the pharmaceutical industry has made significant investments in this therapeutic area. Despite these efforts, cancer drug research remains a remarkably challenging field, and therapeutic innovations have not yet achieved anticipated clinical results. However, the patholophysiology of the disease is now better understood, and the discovery of novel molecular targets has raised the expectations of developing improved treatments. Several noteworthy advances have been made, among which the development of targeted therapies is the most improvement. Monoclonal antibodies and antibody-small molecule conjugates have emerged as an effective approach to improve drug selectivity and reduce adverse effects, which are the main challenges in cancer drug discovery.
The most widely used treatments for cancer are surgery, radiotherapy and chemotherapy. Chemotherapy is the best existing option for metastatic cancers, where the treatment has to be systemic. The most frequently used chemotherapy drugs have been identified empirically without any pre-existing knowledge regarding the molecular mechanism of action of the drugs.
Related Associations: James Cancer Hospital & Solove Research Institute, Peter McCollum Health Centre, University of Washington Medical Center/Seattle Cancer Care Alliance, Georgetown Lombardi Comprehensive Cancer Center, Epworth Radiation Oncology, Hong Kong Adventist Hospital, Townsville Cancer Centre, Tata Memorial Centre, American Oncology Institute, Mahatma Gandhi Cancer Hospital & Research Institute, University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center
Related Conferences: Cancer Nursing Summit, Oncology and Cancer Care Events, Pain Management Meetings, Cancer Summit, Nursing Events, Primary Health Care Meetings, Nursing Meetings, Cancer Nursing Conferences, Cancer Care Meetings, Nursing Workshops, Cancer Care events, Cancer Nursing Events, Nursing Education Conferences, Nursing Conferences, Pain Management Summits
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
